Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia.
Pavletic ZS, Arrowsmith ER, Bierman PJ, Goodman SA, Vose JM, Tarantolo SR, Stein RS, Bociek G, Greer JP, Wu CD, Kollath JP, Weisenburger DD, Kessinger A, Wolff SN, Armitage JO, Bishop MR. Pavletic ZS, et al. Among authors: goodman sa. Bone Marrow Transplant. 2000 Apr;25(7):717-22. doi: 10.1038/sj.bmt.1702237. Bone Marrow Transplant. 2000. PMID: 10745256
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
Wolff SN, Fay J, Stevens D, Herzig RH, Pohlman B, Bolwell B, Lynch J, Ericson S, Freytes CO, LeMaistre F, Collins R, Pineiro L, Greer J, Stein R, Goodman SA, Dummer S. Wolff SN, et al. Among authors: goodman sa. Bone Marrow Transplant. 2000 Apr;25(8):853-9. doi: 10.1038/sj.bmt.1702233. Bone Marrow Transplant. 2000. PMID: 10808206 Clinical Trial.
High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes.
Engelhardt BG, Holland DW, Brandt SJ, Chinratanalab W, Goodman SA, Greer JP, Jagasia MH, Kassim AA, Morgan DS, Ruffner KL, Schuening FG, Wolff S, Bitting R, Sulur P, Stein RS. Engelhardt BG, et al. Among authors: goodman sa. Leuk Lymphoma. 2007 Sep;48(9):1728-35. doi: 10.1080/10428190701534374. Leuk Lymphoma. 2007. PMID: 17786708
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies.
Kennedy VE, Savani BN, Greer JP, Kassim AA, Engelhardt BG, Goodman SA, Sengsayadeth S, Chinratanalab W, Jagasia M. Kennedy VE, et al. Among authors: goodman sa. Biol Blood Marrow Transplant. 2016 Oct;22(10):1801-1807. doi: 10.1016/j.bbmt.2016.06.029. Epub 2016 Jul 1. Biol Blood Marrow Transplant. 2016. PMID: 27377900 Free article.
Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia.
Gatwood KS, Culos KA, Binari LA, Engelhardt BG, Kassim A, Byrne MT, Goodman SA, Chinratanalab W, Sengsayadeth SM, Greer JP, Jagasia M, Savani BN. Gatwood KS, et al. Among authors: goodman sa. Bone Marrow Transplant. 2018 Jun;53(6):795-799. doi: 10.1038/s41409-018-0124-6. Epub 2018 Mar 14. Bone Marrow Transplant. 2018. PMID: 29540851 No abstract available.
Nocardial infections in bone marrow transplant recipients.
Chouciño C, Goodman SA, Greer JP, Stein RS, Wolff SN, Dummer JS. Chouciño C, et al. Among authors: goodman sa. Clin Infect Dis. 1996 Nov;23(5):1012-9. doi: 10.1093/clinids/23.5.1012. Clin Infect Dis. 1996. PMID: 8922795 Review.
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant Group.
Fleming DR, Wolff SN, Fay JW, Brown RA, Lynch JP, Bolwell BJ, Stevens DA, Goodman SA, Greer JP, Stein RS, Pineiro LA, Collins RH, Goldsmith LJ, Herzig GP, Herzig RH. Fleming DR, et al. Among authors: goodman sa. Leuk Lymphoma. 1999 Sep;35(1-2):91-8. doi: 10.3109/10428199909145708. Leuk Lymphoma. 1999. PMID: 10512166 Clinical Trial.
51 results